SEARCH

SEARCH BY CITATION

References

  • 1
    O'Sullivan BG, Gidding HF, Law M, Kaldor JM, Gilbert GL, Dore GJ. Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health. 2004;28(3):21216.
  • 2
    Department of Health and Ageing. National Hepatitis B Strategy 2010 – 2013. Canberra ( AUST ) : Commonwealth of Australia; 2010 April 22.
  • 3
    Office of Health Protection. The Australian Immunisation Handbook. 9th ed. Canberra ( AUST ) : Commonwealth Department of Health and Ageing; 2008.
  • 4
    Cowie BC. Is it even more cost effective for well resourced, low hepatitis B prevalence countries to vaccinate infants in endemic regions than their own children? J Hepatol. 2011;54 Suppl 1:S146.
  • 5
    MacLachlan JH, Cowie BC. Liver cancer is the fastest increasing cause of cancer death in Australians. Med J Aust. 2012;197(9):4923.
  • 6
    Nguyen VT, Razali K, Amin J, Law MG, Dore GJ. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries. J Gastroenterol Hepatol. 2008;23(6):9229.
  • 7
    Australian Bureau of Statistics. 2006 Census of Population and Housing. Canberra ( AUST ) : ABS; 2007.
  • 8
    Australian Bureau of Statistics. 2011 Census of Population and Housing. Canberra ( AUST ) : ABS; 2012.
  • 9
    Department of Immigration and Citizenship. Trends in Migration: Australia 2010–11. Canberra ( AUST ) : Commonwealth of Australia; 2012.
  • 10
    Gidding HF, Warlow M, MacIntyre CR, Backhouse J, Gilbert GL, Quinn HE, et al. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine. 2007;25(51):863741.
  • 11
    Smith AM, Rissel CE, Richters J, Grulich AE, de Visser RO. Sex in Australia: sexual identity, sexual attraction and sexual experience among a representative sample of adults. Aust N Z J Public Health. 2003;27(2):13845.
  • 12
    Australian Institute of Health and Welfare. 2010 National Drug Strategy Household Survey Report. Drug Statistics Series No.: 25. Catalogue No.: PHE 145. Canberra ( AUST ) : AIHW; 2011.
  • 13
    Turnour CE, Cretikos MA, Conaty SJ. Prevalence of chronic hepatitis B in South Western Sydney: evaluation of the country of birth method using maternal seroprevalence data. Aust N Z J Public Health. 2011;35(1):226.
  • 14
    Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology. 2012;56(2):42233.
  • 15
    Anderson B, Bodsworth NJ, Rohrsheim RA, Donovan BJ. Hepatitis B virus infection and vaccination status of high risk people in Sydney: 1982 and 1991. Med J Aust. 1994;161(6):36871.
  • 16
    Burrell CJ, Cameron AS, Hart G, Melbourne J, Beal RW. Hepatitis B reservoirs and attack rates in an Australian community. A basis for vaccination and crossinfection policies. Med J Aust. 1983;2(10):4926.
  • 17
    Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378(9791):57183.
  • 18
    Richards M, Lucas CR, Gust I. Hepatitis in male homosexuals in Melbourne. Med J Aust. 1983;2(10):4745.
  • 19
    Graham S, Guy R, Akre S, Cowie B, Ward J. Hepatitis B among Aboriginal and Torres Strait Islander People – Key Sub-groups. Proceedings of the Australasian Sexual Health Conference; 2011 Sep 26–30; Canberra, Aust. Canberra : Australasion Society for HIV Medicine; 2011.
  • 20
    Schultz R, Romanes F, Krause V. Hepatitis B prevalence and prevention: antenatal screening and protection of infants at risk in the Northern Territory. Aust N Z J Public Health. 2008;32(6):5756.
  • 21
    Wood N, Warlow M, Quinn H, Selvey C, Lum G, McIntyre P, et al. Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia. Aust N Z J Public Health. 2008;32(3):2725.
  • 22
    Australian Bureau of Statistics. 2001 Census of Population and Housing. Canberra ( AUST ) : ABS; 2002.
  • 23
    Cowie BC, Kelly H. Developing a mathematical model of hepatitis B in Australia – a new way of engaging an ancient, emergent pathogen (PP-028). Hepatol Int. 2010;4(1):101.
  • 24
    HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report 2012. Sydney ( AUST ) : The University of New South Wales, The Kirby Institute; 2012.
  • 25
    Cowie B, Karapanagiotidis T, Enriquez A, Kelly H. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005. Aust N Z J Public Health. 2010;34(1):728.
  • 26
    Hepatitis B Program, Epidemiology Unit, VIDRL. Estimated number of people living with hepatitis B virus infection in 2011. In: HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report 2012. Sydney ( AUST ) : The University of New South Wales, Kirby Institute; 2012.
  • 27
    Australian Bureau of Statistics. Population Projections, Australia, 2004 to 2101. Catalogue No.: 3222.0. Canberra ( AUST ) : ABS; 2006.
  • 28
    Department of Health and Ageing. National Health Reform Agreement. Canberra ( AUST ) : Commonwealth of Australia; 2011 [cited 2012 Nov 26]. Available from: http://www.yourhealth.gov.au/internet/yourhealth/publishing.nsf/Content/nhra-agreement.
  • 29
    Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):65507.
  • 30
    Progress Towards Meeting the 2012 Hepatitis B Control Milestone: WHO Western Pacific Region, 2011. Wkly Epidemiol Rec. 2011;86(19):1808.
  • 31
    Cowie B. The linguistic demography of Australians living with chronic hepatitis B. Aust N Z J Public Health. 2011;35(1):125.
  • 32
    Anikeeva O, Bi P, Hiller JE, Ryan P, Roder D, Han G-S. The health status of migrants in Australia: a review. Asia Pac J Public Health. 2010;22(2):15993.
  • 33
    Weber MF, Banks E, Smith DP, O'Connell D, Sitas F. Cancer screening among migrants in an Australian cohort; cross-sectional analyses from the 45 and Up Study. BMC Public Health. 2009;9:144.
  • 34
    Global Hepatitis Programme. Prevention and Control of Viral Hepatitis Infection: Framework for Global Action. Geneva ( CHE ) : World Health Organisation; 2012.
  • 35
    Cowie B, Dore G. The perpetual challenge of infectious diseases. N Engl J Med. 2012;367(1):8990.
  • 36
    Robotin MC, Kansil M, Howard K, George J, Tipper S, Dore GJ, et al. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. J Hepatol. 2009;50(5):9908.
  • 37
    Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol. 2010;53(2):34856.